Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03919643
What this trial is testing

BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE

Who this might be right for
Systemic Lupus ErythematosusBAFF Polymorphism
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 200
Not applicableStudy completedNCT00029926
What this trial is testing

Positron Emission Tomography (PET) to Locate Areas of White Blood Cell Activity

Who this might be right for
Lupus ErythematosusSystemic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 20
Not applicableStudy completedNCT02084238
What this trial is testing

Low-dose IL-2( Interleukin-2) Treatment in SLE

Who this might be right for
Systemic Lupus Erythematosus
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07564596
What this trial is testing

A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erthematosus
Climb Bio, Inc. 30
Not applicableUnknownNCT01460680
What this trial is testing

Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE)

Who this might be right for
FibromyalgiaSystemic Lupus Erythematosus
Tel-Aviv Sourasky Medical Center 300
Testing effectiveness (Phase 2)UnknownNCT03396393
What this trial is testing

Exploratory Study of DHA in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Kunming Pharmaceuticals, Inc. 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT07721324
What this trial is testing

Effect of Melatonin Administration on Systemic Lupus Erythematosus Patients

Who this might be right for
TherapyTreatment
Ain Shams University 64
Not applicableLooking for participantsNCT05698173
What this trial is testing

Systemic Lupus Erythematosus and Accelerated Aging

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Bordeaux 75
Testing effectiveness (Phase 2)UnknownNCT03917797
What this trial is testing

Mesenchymal Stromal Cells (MSC´s) in Renal Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus Glomerulonephritis
Universidad de los Andes, Chile 39
Early research (Phase 1)Study completedNCT03262727
What this trial is testing

The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients

Who this might be right for
Systemic Lupus ErythematosusArthritic PsoriasisPsoriasis+1 more
Bristol-Myers Squibb 49
Early research (Phase 1)Looking for participantsNCT06647069
What this trial is testing

Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Rheumatoid Arthritis (RA)
Sanofi 62
Not applicableStudy completedNCT02631005
What this trial is testing

Walk With Ease Program For Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
University of North Carolina, Chapel Hill 76
Testing effectiveness (Phase 2)Study completedNCT02349061
What this trial is testing

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
Janssen Research & Development, LLC 102
Very early researchWithdrawnNCT07410377
What this trial is testing

UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusInflammatory Myopathy
The Affiliated Hospital of Xuzhou Medical University
Testing effectiveness (Phase 2)Active Not RecruitingNCT06015230
What this trial is testing

Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE

Who this might be right for
Lupus Erythematosus, Systemic
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT00556192
What this trial is testing

Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Chinese University of Hong Kong 20
Not applicableLooking for participantsNCT06804057
What this trial is testing

CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

Who this might be right for
Systemic Lupus Erythematosus
CorEvitas 1,000
Not applicableUnknownNCT05106998
What this trial is testing

NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity

Who this might be right for
System Lupus Erythematosus
Assiut University 85
Large-scale testing (Phase 3)Enrolling By InvitationNCT04976322
What this trial is testing

Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Biopharma SRL 760
Early research (Phase 1)Study completedNCT02321709
What this trial is testing

Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients

Who this might be right for
Systemic Lupus Erythematosus
Sanofi 21
Next Page